Midi Health vs LifeMD

Compare pricing, features, and medications to find the best GLP-1 provider for your weight loss journey

Midi Health vs LifeMD: Overview

Choosing between Midi Health and LifeMD for GLP-1 weight loss medication? Both are highly-rated providers, but they differ in pricing, medication options, and service features.

Midi Health offers both semaglutide and tirzepatide at $164/month with a rating of 8.6/10. LifeMD also provides both semaglutide and tirzepatide at $199/month with a 8.5/10 rating.

With only a $35/month price difference, your choice will likely come down to features, support quality, and medication options.

VERIFIED

Our recommended brand

After reviewing all 148 providers on this platform, we've identified CoreAge Rx as offering the most transparent pricing model. At just $99/month — the same price every month, every dose — there are no surprise charges or hidden fees. Combined with exceptional service quality, personalized support, and access to both semaglutide and tirzepatide, it represents the best value without compromising on care.

At a glance

Price Difference
$35/mo
Rating Difference
0.1
Winner
Midi Health
Best For
Budget

Midi Health

View full Midi Health review →
Rating
8.6/10Better
Monthly Price
$164Cheaper
Medications
compounded GLP-1compounded GLP-1/GIPbrand-name GLP-1s

Pros

  • The GLP-1 pricing page is the most transparent we have seen anywhere in this category: a dose-by-dose table for four different products, with shipping and supplies included in every figure (checked July 28, 2026)
  • Compounded GLP-1 injectable runs $165.90 for the lowest doses, $270.90 in the mid range and $355.00 at the top; the dual-action GLP-1/GIP injectable runs $210.00 to $434.00, all for a 4-week supply
  • Sublingual options are offered as well, from $164.00 for GLP-1 and $209.00 for dual-action GLP-1/GIP, for people who will not inject
  • Its partner compounding pharmacies are 503B-accredited. 503B outsourcing facilities register with the FDA, are subject to current good manufacturing practice requirements and are FDA-inspected - a materially higher standard than the 503A pharmacies most competitors use
  • There is no membership fee. You pay for care and medication only
  • Visits are insurance-covered for qualifying patients, and HSA/FSA funds can be used for copays and services
  • Midi will also prescribe brand-name GLP-1s sent to a pharmacy of your choice, so you are not locked into compounded product if you would rather have the approved drug
  • The efficacy claim is the best-sourced in this category. Midi reports patients lost an average of 16 lbs after six or more months, and footnotes it to a retrospective analysis of 6,958 patients who completed two or more weight management visits between 1 May 2025 and 30 April 2026, while stating plainly that weight data were self-reported and results are not guaranteed
  • Care is genuinely whole-person for midlife women - perimenopause, menopause, weight, mood and memory, sexual wellness, hair and skin, sleep, and cancer survivorship - with lab orders and lifestyle support included where appropriate
  • Available in all 50 states

Cons

  • The compounded products are still not FDA-approved. 503B accreditation raises the manufacturing standard considerably but does not mean the FDA has reviewed these preparations for safety or efficacy
  • Midi never names the active drug anywhere in its pricing. Everything is labelled 'GLP-1' or 'GLP-1/GIP'. The dose ladders shown - 0.25 through 2.5 mg, and 2.5 through 15 mg - match the standard semaglutide and tirzepatide titrations exactly, but you should confirm with the clinician what you are actually being prescribed
  • Microdosing is offered from $34 a week for eligible patients. Microdosing is not an evidence-based protocol - the trials behind these drugs used full therapeutic doses, and the 16 lb outcome figure covers patients on 'a range of treatments', not microdosing specifically
  • Medicaid and Medi-Cal patients cannot be treated at all, even if they offer to pay cash
  • Medicare does not cover Midi, and beneficiaries cannot submit claims for visits, medications or associated services
  • Prices rise steeply as you titrate up. Injectable GLP-1 more than doubles from $165.90 to $355.00, and the dual-action sublingual runs from $209.00 to $460.00, so the entry price is not what you will pay long term
  • The 16 lb average comes from self-reported weights in a retrospective chart review with no control group - well documented, but not a controlled trial
  • GLP-1 medications are not suitable for anyone with a personal or family history of medullary thyroid carcinoma or MEN 2, or during pregnancy. Pancreatitis and gallbladder disease are recognised risks
Choose Midi Health

LifeMD

View full LifeMD review →
Rating
8.5/10
Monthly Price
$199
Medications
semaglutidetirzepatide

Pros

  • Prescribes FDA-approved branded GLP-1s - Zepbound and Wegovy - rather than compounded preparations, so you get the exact product the trials studied
  • Accepts insurance including Medicare, and advertises as low as $0 copay for branded GLP-1s where coverage applies
  • Publishes cash prices too: Wegovy Pen from $199/month and Zepbound Vial from $349/month (checked July 28, 2026)
  • Offers an outcome-based guarantee: 'lose 10% of your weight or your money back', which ties the promise to a result rather than a satisfaction survey
  • HSA and FSA eligible
  • Weight care sits inside a full telehealth service, so urgent care, labs and other specialties are available under the same account

Cons

  • The rotating banner on the weight-management page shows the Wegovy Pen at both '$199' and '$499' in the same carousel, which makes the real starting price unclear before you sign up
  • The money-back guarantee carries a footnote marker on site, so read the qualifying conditions before relying on it
  • Insurance coverage for obesity medication is patchy, so the '$0 copay' outcome will not apply to many people and the cash prices are what you should plan around
  • A 4.0 Trustpilot average is mid-range for this category
  • Branded GLP-1s at $199-$349/month are more expensive than compounded alternatives, which is the trade-off for using an FDA-approved product
  • GLP-1 medications are not suitable for anyone with a personal or family history of medullary thyroid carcinoma or MEN 2, or during pregnancy
Choose LifeMD

Feature-by-feature comparison

FeatureMidi HealthLifeMD
Monthly Price$164$199
Rating8.6/108.5/10
Medicationscompounded GLP-1, compounded GLP-1/GIP, brand-name GLP-1ssemaglutide, tirzepatide
Insurance AcceptedYesYes
Support HoursNot publishedMon-Fri 8AM-8PM ET
Live ChatNoAvailable
Free ShippingYesYes
Shipping SpeedDiscreet shipping included in every quoted medication price3-5 days
Mobile AppNoAvailable
Dedicated CoachNot includedNot included
Follow-up FrequencyContinued care visits with the same clinician, covered by insurance for qualifying patientsQuarterly
Money-back GuaranteeNone publishedLose 10% of your weight or your money back (conditions apply)
Cancellation PolicyNo membership fee and no subscription lock-in; you pay for care and medication onlyCancel anytime

Which should you choose?

Choose Midi Health if you:

  • Want to save $35/month with a more affordable option
  • Prefer a higher-rated service (8.6/10 vs 8.5/10)
  • Want more medication options to choose from
  • Value: the glp-1 pricing page is the most transparent we have seen anywhere in this category: a dose-by-dose table for four different products, with shipping and supplies included in every figure (checked july 28, 2026)

Choose LifeMD if you:

  • Value: prescribes fda-approved branded glp-1s - zepbound and wegovy - rather than compounded preparations, so you get the exact product the trials studied

Website previews

Midi Health

Midi Health website

LifeMD

LifeMD website

Our recommendation

Midi Health comes out ahead with a higher rating of 8.6/10. It also provides multiple medication options including both semaglutide and tirzepatide.
Get started with Midi Health

Compare other providers

Compare GLP-1 Brands